• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过酵母展示工程化抗体。

Engineering antibodies by yeast display.

机构信息

Department of Chemical and Biomolecular Engineering, University of Tennessee, Knoxville, TN 37996-2200, USA.

出版信息

Arch Biochem Biophys. 2012 Oct 15;526(2):99-106. doi: 10.1016/j.abb.2012.03.009. Epub 2012 Mar 19.

DOI:10.1016/j.abb.2012.03.009
PMID:22450168
Abstract

Since its first application to antibody engineering 15 years ago, yeast display technology has been developed into a highly potent tool for both affinity maturing lead molecules and isolating novel antibodies and antibody-like species. Robust approaches to the creation of diversity, construction of yeast libraries, and library screening or selection have been elaborated, improving the quality of engineered molecules and certainty of success in an antibody engineering campaign and positioning yeast display as one of the premier antibody engineering technologies currently in use. Here, we summarize the history of antibody engineering by yeast surface display, approaches used in its application, and a number of examples highlighting the utility of this method for antibody engineering.

摘要

自 15 年前首次应用于抗体工程以来,酵母展示技术已发展成为一种非常有效的亲和力成熟先导分子的工具,同时也可用于分离新型抗体和抗体样物质。已经详细阐述了创建多样性、构建酵母文库以及文库筛选或选择的稳健方法,从而提高了工程分子的质量,并确保了抗体工程中的成功率,使酵母展示成为目前使用的主要抗体工程技术之一。在这里,我们总结了通过酵母表面展示进行抗体工程的历史、应用中使用的方法以及一些突出该方法在抗体工程中实用性的实例。

相似文献

1
Engineering antibodies by yeast display.通过酵母展示工程化抗体。
Arch Biochem Biophys. 2012 Oct 15;526(2):99-106. doi: 10.1016/j.abb.2012.03.009. Epub 2012 Mar 19.
2
Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage.与从展示在噬菌体上的相同文库中进行筛选相比,从展示在酵母上的HIV-1免疫抗体文库中进行抗原筛选可产生许多新型抗体。
Protein Eng Des Sel. 2007 Feb;20(2):81-90. doi: 10.1093/protein/gzl057. Epub 2007 Jan 22.
3
Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.从小鼠骨髓和脾脏构建非免疫单链抗体噬菌体展示文库的最佳方法已确立,以便有效筛选出能与抗原特异性结合的单链抗体。
Biochem Biophys Res Commun. 2004 Oct 15;323(2):583-91. doi: 10.1016/j.bbrc.2004.08.131.
4
Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris.从展示在毕赤酵母表面的免疫文库中分离抗原结合骆驼重链抗体片段(纳米抗体)。
J Biotechnol. 2010 Jan 15;145(2):93-8. doi: 10.1016/j.jbiotec.2009.10.010. Epub 2009 Oct 25.
5
The rapid discovery of engineered antibodies.工程抗体的快速发现。
IDrugs. 2007 Aug;10(8):562-5.
6
An improved yeast transformation method for the generation of very large human antibody libraries.一种改良的酵母转化方法,用于生成非常大的人抗体文库。
Protein Eng Des Sel. 2010 Apr;23(4):155-9. doi: 10.1093/protein/gzq002. Epub 2010 Feb 3.
7
Selection of antibodies from synthetic antibody libraries.从合成抗体文库中筛选抗体。
Arch Biochem Biophys. 2012 Oct 15;526(2):87-98. doi: 10.1016/j.abb.2011.12.028. Epub 2012 Jan 8.
8
Therapeutic antibody engineering by high efficiency cell screening.通过高效细胞筛选进行治疗性抗体工程。
FEBS Lett. 2014 Jan 21;588(2):278-87. doi: 10.1016/j.febslet.2013.11.025. Epub 2013 Nov 26.
9
Protein selection using yeast surface display.利用酵母表面展示技术进行蛋白质筛选。
Methods. 2013 Mar 15;60(1):15-26. doi: 10.1016/j.ymeth.2012.03.014. Epub 2012 Mar 23.
10
Whole IgG surface display on mammalian cells: Application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies.全IgG在哺乳动物细胞表面的展示:用于分离中和性鸡抗IL-12单克隆抗体
J Immunol Methods. 2007 Oct 31;327(1-2):40-52. doi: 10.1016/j.jim.2007.07.007. Epub 2007 Aug 2.

引用本文的文献

1
Unlocking the potential of tumor-targeting peptides in precision oncology.释放肿瘤靶向肽在精准肿瘤学中的潜力。
Oncol Res. 2025 Jun 26;33(7):1547-1570. doi: 10.32604/or.2025.062197. eCollection 2025.
2
Generating combinatorial diversity via engineered V(D)J-like recombination in Saccharomyces cerevisiae.通过酿酒酵母中工程化的V(D)J样重组产生组合多样性。
Nat Commun. 2025 Jul 1;16(1):5688. doi: 10.1038/s41467-025-61206-1.
3
Bio-Inspired Mamba for Antibody-Antigen Interaction Prediction.用于抗体 - 抗原相互作用预测的仿生曼巴算法
Biomolecules. 2025 May 26;15(6):764. doi: 10.3390/biom15060764.
4
FASTIA: A rapid and accessible platform for protein variant interaction analysis demonstrated with a single-domain antibody.FASTIA:一个用于蛋白质变体相互作用分析的快速且易于使用的平台,通过单域抗体进行了验证。
Protein Sci. 2025 Mar;34(3):e70065. doi: 10.1002/pro.70065.
5
Determining key residues of engineered scFv antibody variants with improved MMP-9 binding using deep sequencing and machine learning.利用深度测序和机器学习确定具有改善的基质金属蛋白酶-9结合能力的工程化单链抗体片段(scFv)变体的关键残基。
Comput Struct Biotechnol J. 2024 Oct 10;23:3759-3770. doi: 10.1016/j.csbj.2024.10.005. eCollection 2024 Dec.
6
Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects.哺乳动物展示技术在治疗性抗体开发及其他领域的进展:现状、挑战与未来展望。
Front Immunol. 2024 Sep 24;15:1469329. doi: 10.3389/fimmu.2024.1469329. eCollection 2024.
7
Synthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits.酵母展示发现的合成整联蛋白抗体揭示 αV 亚基与 β 亚基的配对偏好。
MAbs. 2024 Jan-Dec;16(1):2365891. doi: 10.1080/19420862.2024.2365891. Epub 2024 Jun 18.
8
A synergistic therapy against influenza virus A/H1N1/PR8 by a HA1 specific neutralizing single-domain V and an RNA hydrolyzing scFv.一种由HA1特异性中和单域V和RNA水解单链抗体片段组成的抗甲型H1N1/PR8流感病毒的协同疗法。
Front Microbiol. 2024 Apr 19;15:1355599. doi: 10.3389/fmicb.2024.1355599. eCollection 2024.
9
Machine learning for functional protein design.用于功能性蛋白质设计的机器学习
Nat Biotechnol. 2024 Feb;42(2):216-228. doi: 10.1038/s41587-024-02127-0. Epub 2024 Feb 15.
10
Synthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits.通过酵母展示发现的合成整合素抗体揭示了αV亚基与β亚基的配对偏好。
bioRxiv. 2024 Jan 27:2024.01.26.577394. doi: 10.1101/2024.01.26.577394.